A chapter in the development of Alzheimer's disease research: A case study of public policies on the development and funding of research programs

Alzheimer's and Dementia

Volumn 3, Issue 3, 2007, Pages 243-258

  Khachaturian, Zaven S ^a  

^a Lou Ruvo Brain Institute   (United States)

Author keywords

Alzheimer's disease; Basic research; Diagnosis; History; National Institute of Aging; Prevention; Public policy; Screening; Treatment

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; ANTIINFLAMMATORY AGENT; DONEPEZIL; GALANTAMINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RIVASTIGMINE; ROSIGLITAZONE; TACRINE; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CASE STUDY; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DISEASE SEVERITY; FINANCIAL MANAGEMENT; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEALTH CARE POLICY; HEALTH PROGRAM; HISTOPATHOLOGY; HISTORY OF MEDICINE; HUMAN; INFLAMMATORY DISEASE; MEDICAL CARE; MEDICAL RESEARCH; NEUROPSYCHOLOGICAL TEST; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT CARE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; RISK ASSESSMENT; RISK FACTOR;

EID: 34249748954     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2007.04.379     Document Type: Article

References (57)

1. Berchtold N.C., and Cotman C.W. Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s. Neurobiol Aging 19 (1998) 173-189
2. Beach T.G. The history of Alzheimer's disease: three debates. J Hist Med Allied Sci 42 (1987) 327-349
3. Bick K.L., Amaducci L., and Pepeu G. The early history of Alzheimer's disease (1987), Raven Press, New York
4. Braak H., and Braak E. Neurofibrillary changes: the hallmark of Alzheimer disease. In: Whitehouse P.J., Maurer K., and Ballenger J.F. (Eds). Concepts of Alzheimer disease: biological, clinical, and cultural perspectives (2000), Johns Hopkins Press, Baltimore 53-71
5. Maurer K., Volk S., and Gerbaldo H. The history of Alois Alzheimer's first case. In: Whitehouse P.J., Maurer K., and Ballenger J.F. (Eds). Concepts of Alzheimer disease: biological, clinical, and cultural perspectives (2000), Johns Hopkins Press, Baltimore 5-29
6. Dillmann R.J. Alzheimer's disease: epistemological lessons from history. In: Whitehouse P.J., Maurer K., and Ballenger J.F. (Eds). Concepts of Alzheimer disease: biological, clinical, and cultural perspectives (2000), Johns Hopkins Press, Baltimore 129-157
7. Blessed G., Tomlinson B.E., and Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114 (1968) 797-811
8. Yu E.S., Liu W.T., Levy P., Zhang M.Y., Katzman R., Lung C.T., et al. Cognitive impairment among elderly adults in Shanghai, China. J Gerontol 44 (1989) S97-S106
9. In: Katzman R., Terry R.D., and Bick K.L. (Eds). Alzheimer's disease: senile dementia and related disorders, aging (1978), Raven Press, New York
10. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
11. Rosen W.G., Mohs R.C., and Davis K.L. A new rating scale for Alzheimer's disease. Am J Psychiatry 141 (1984) 1356-1364
12. Katzman R. Editorial: the prevalence and malignancy of Alzheimer disease. A major killer. Arch Neurol 33 (1976) 217-218
13. Diagnostic and statistical manual of mental disorders. Third edition-revised (1987), American Psychiatric Association, Washington, DC
14. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
15. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch Neurol 42 (1985) 1097-1105
16. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
17. Braak H., and Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol [Berl] 82 (1991) 239-259
18. +)-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. EMBO J 9 (1990) 3539-3544
19. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 18 Suppl. 4 (1997) S1-S2
20. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Work Group. Consensus Report of the Work Group. Molecular and biochemical markers of Alzheimer's disease. Neurobiol Aging 19 (1998) 109-116
21. Petersen R.C. Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia 15 (2000) 93-101
22. Cummings J.L., Vinters H., and Felix J. The neuropsychiatry of Alzheimer's disease and related dementias (2003), Martin Dunitz, London
23. Davies P., and Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet (1976) 2.1403
24. Khachaturian Z.S. 1984. Towards theories of brain aging. In: Kay D.S., and Burrows G.W. (Eds). Handbook of studies on psychiatry and old age (1984), Elsevier, Amsterdam 7-30
25. Khachaturian Z.S. The role of calcium regulation in brain aging: re-examination of a hypothesis. Aging 1 (1989) 17-34
26. Khachaturian Z.S. Calcium hypothesis of Alzheimer's disease and brain aging. Ann NY Acad Sci 747 (1994) 1-11
27. O'Neill C., Cowburn R.F., Bonkale W.L., Ohm T.G., Fastbom J., Carmody M., et al. Dysfunctional intracellular calcium homeostasis: central cause of neurodegeneration in Alzheimer's disease. Biochem Soc Symp 67 (2001) 177-194
28. LaFerla F.M. Calcium dyshomeostatis and intracellular signaling in Alzheimer's disease. Nat Rev Neurosci 3 (2002) 862-872
29. Glenner G.G., and Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120 (1984) 885-890
30. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., and Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82 (1985) 4245-4249
31. Goldgaber D.C., Lerman M.I., McBride O.W., Saffiotti U., and Gajdusek D.C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235 (1987) 877-890
32. Kang J., Lemaire H.-G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.-H., et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 (1987) 733-736
33. Robakis N.K., Wisniewski H.M., Jenkins E.C., Devine-Gage E.A., Houck G.E., Yao X.-L., et al. Chromosome 21q21 sublocalisation of gene encoding beta-amyloid peptide in cerebral vessels and neuritic [senile] plaques of people with Alzheimer disease and Down syndrome. Lancet 1 (1987) 384-385
34. Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A.P., St. George-Hyslop P.H., VanKeuren M.L., et al. Amyloid beta-protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science 235 (1987) 880-884
35. St. George-Hyslop P.H., Tanzi R.E., Polinsky R.J., Haines J.L., Nee L., Watkins P.C., et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235 (1987) 885-890
36. Schellenberg G.D., Bird T.D., Wijsman E.M., Orr H.T., Anderson L., Nemens E., et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258 (1992) 668-671
37. St. George-Hyslop P., Haines J., Rogaev E., Mortilla M., Vaula G., Pericak-Vance M., et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet 2 (1992) 330-334
38. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 (1991) 704-706
39. Sisodia S.S., Koo E.H., Beyreuther K., Unterbeck A., and Price D.L. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248 (1990) 492-495
40. Vassar R., and Citron M. Abeta-generating enzymes: recent advances in beta- and gamma-secretase research. Neuron 27 (2000) 419-422
41. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81 (2001) 741-766
42. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 (1999) 173-177
43. Busciglio J., Lorenzo A., Yeh J., and Yankner B.A. Beta-amyloid fibrils induce Tau phosphorylation and loss of microtubule binding. Neuron 14 (1995) 879-888
44. Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G., et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant Tau and APP. Science 293 (2001) 1487-1491
45. Lee V.M.-Y., Balin B.J., Otvos Jr. L., and Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251 (1991) 675-678
46. Goedert M., Wischik C.M., Crowther R.A., Walker J.E., and Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein Tau. Proc Natl Acad Sci USA 85 (1988) 4051-4055
47. Delacourte A., and Buee L. Tau pathology: a marker of neurodegenerative disorders. Curr Opin Neurol 13 (2000) 371-376
48. Lee V.M., Goedert M., and Trojanowski J.Q. Neurodegenerative Tauopathies. Annu Rev Neurosci 24 (2001) 1121-1159
49. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., and Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33 (2000) 95-130
50. De La Torre J.C. Impaired cerebromicrovascular perfusion: summary of evidence in support of its causality in Alzheimer's disease. Ann NY Acad Sci 924 (2000) 136-152
51. Blass J.P. The mitochondrial spiral: an adequate cause of dementia in the Alzheimer's syndrome. Ann NY Acad Sci 924 (2000) 170-183
52. Beal M.F. Oxidative metabolism. Ann NY Acad Sci 924 (2000) 164-169
53. Roses A.D., and Saunders A.M. Perspective on a pathogenesis and treatment of Alzheimer's disease. Alzheimers Dement 2 (2006) 59-70
54. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
55. McGeer P.L., and McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21 (1995) 195-218
56. Rogers J., and Shen Y. A perspective on inflammation in Alzheimer's disease. Ann NY Acad Sci 924 (2000) 132-135
57. Alzheimer's disease. a compendium of current theories. In: Khachaturian Z.S., and Mesulam M.M. (Eds). Ann NY Acad Sci 924 (2000) 184-193